Overview Dividends

(INGR) Ingredion - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4571871023

Starches, Sweeteners, Corn Oil, Gluten Feed, Biomaterials

INGR EPS (Earnings per Share)

EPS Growth (3Y CAGR): -52.29%
EPS Trend (3Y Correlation): -25.4%

INGR Revenue

Revenue Growth (3Y CAGR): -3.52%
Revenue Trend (3Y Correlation): -86.9%

Description: INGR Ingredion November 03, 2025

Ingredion Incorporated (NYSE: INGR) manufactures and markets a broad portfolio of corn-derived ingredients-including sweeteners, starches, nutrition ingredients, and biomaterial solutions-serving food & beverage, paper, textile, construction, pharmaceutical, cosmetics, and specialty industrial markets worldwide. Its product set spans everything from glucose syrups and high-fructose corn syrup to specialty starches for biodegradable plastics and water-filtration applications.

Key metrics and sector drivers: In fiscal 2023 the company generated roughly $6.5 billion in revenue with an adjusted EBITDA margin near 10 %, reflecting strong pricing power in high-growth “clean-label” and plant-based food segments. Ingredient demand is closely tied to corn commodity prices and global food-security trends, while end-market exposure to the expanding snack-and-convenience sector underpins volume growth. Additionally, Ingredion’s recent acquisitions in the specialty bioplastics space aim to capture a projected $45 billion market opportunity by 2030.

For a deeper quantitative view of INGR’s valuation and risk profile, you may find the ValueRay platform useful.

INGR Stock Overview

Market Cap in USD	7,325m
Sub-Industry	Agricultural Products & Services
IPO / Inception	1997-12-11

INGR Stock Ratings

Growth Rating	8.07%
Fundamental	64.4%
Dividend Rating	53.5%
Return 12m vs S&P 500	-40.1%
Analyst Rating	3.43 of 5

INGR Dividends

Dividend Yield 12m	2.99%
Yield on Cost 5y	5.07%
Annual Growth 5y	-1.82%
Payout Consistency	97.7%
Payout Ratio	38.0%

INGR Growth Ratios

Growth Correlation 3m	-87.4%
Growth Correlation 12m	-63%
Growth Correlation 5y	92%
CAGR 5y	8.31%
CAGR/Max DD 3y (Calmar Ratio)	0.29
CAGR/Mean DD 3y (Pain Ratio)	1.17
Sharpe Ratio 12m	0.05
Alpha	-33.39
Beta	0.735
Volatility	42.41%
Current Volume	1099.7k
Average Volume 20d	500.9k
Stop Loss	104.4 (-3.1%)
Signal	-0.69

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (676.0m TTM) > 0 and > 6% of Revenue (6% = 439.0m TTM)

FCFTA 0.10 (>2.0%) and ΔFCFTA -3.76pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 30.80% (prev 24.23%; Δ 6.57pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.15 (>3.0%) and CFO 1.18b > Net Income 676.0m (YES >=105%, WARN >=100%)

Net Debt (926.0m) to EBITDA (1.20b) ratio: 0.77 <= 3.0 (WARN <= 3.5)

Current Ratio 2.78 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (65.6m) change vs 12m ago -1.80% (target <= -2.0% for YES)

Gross Margin 25.57% (prev 21.83%; Δ 3.74pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 97.53% (prev 106.8%; Δ -9.29pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 31.68 (EBITDA TTM 1.20b / Interest Expense TTM 31.0m) >= 6 (WARN >= 3)

Altman Z'' 6.36

(A) 0.29 = (Total Current Assets 3.52b - Total Current Liabilities 1.26b) / Total Assets 7.78b

(B) 0.69 = Retained Earnings (Balance) 5.38b / Total Assets 7.78b

(D) 1.26 = Book Value of Equity 4.43b / Total Liabilities 3.50b

Total Rating: 6.36 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 64.36

1. Piotroski 6.50pt = 1.50

2. FCF Yield 9.74% = 4.87

3. FCF Margin 10.98% = 2.74

4. Debt/Equity 0.42 = 2.41

5. Debt/Ebitda 0.77 = 2.05

6. ROIC - WACC (= 5.73)% = 7.17

7. RoE 16.76% = 1.40

8. Rev. Trend -86.91% = -6.52

9. EPS Trend -25.40% = -1.27

What is the price of INGR shares?

As of November 06, 2025, the stock is trading at USD 107.70 with a total of 1,099,652 shares traded.
Over the past week, the price has changed by -6.92%, over one month by -10.42%, over three months by -14.15% and over the past year by -28.73%.

Is Ingredion a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Ingredion is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 64.36 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of INGR is around 95.62 USD . This means that INGR is currently overvalued and has a potential downside of -11.22%.

Is INGR a buy, sell or hold?

Ingredion has received a consensus analysts rating of 3.43. Therefor, it is recommend to hold INGR.

Strong Buy: 1
Buy: 1
Hold: 5
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the INGR price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	142.8	32.6%
Analysts Target Price	142.8	32.6%
ValueRay Target Price	105.3	-2.2%

INGR Fundamental Data Overview November 05, 2025

Market Cap USD = 7.32b (7.32b USD * 1.0 USD.USD)
P/E Trailing = 11.1455
P/E Forward = 10.0503
P/S = 1.0012
P/B = 1.807
P/EG = 1.3311
Beta = 0.735
Revenue TTM = 7.32b USD
EBIT TTM = 982.0m USD
EBITDA TTM = 1.20b USD
Long Term Debt = 1.74b USD (from longTermDebt, last quarter)
Short Term Debt = 46.0m USD (from shortTermDebt, last quarter)
Debt = 1.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 926.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.24b USD (7.32b + Debt 1.79b - CCE 868.0m)
Interest Coverage Ratio = 31.68 (Ebit TTM 982.0m / Interest Expense TTM 31.0m)
FCF Yield = 9.74% (FCF TTM 803.0m / Enterprise Value 8.24b)
FCF Margin = 10.98% (FCF TTM 803.0m / Revenue TTM 7.32b)
Net Margin = 9.24% (Net Income TTM 676.0m / Revenue TTM 7.32b)
Gross Margin = 25.57% ((Revenue TTM 7.32b - Cost of Revenue TTM 5.45b) / Revenue TTM)
Gross Margin QoQ = 26.02% (prev 25.70%)
Tobins Q-Ratio = 1.06 (Enterprise Value 8.24b / Total Assets 7.78b)
Interest Expense / Debt = 0.67% (Interest Expense 12.0m / Debt 1.79b)
Taxrate = 23.55% (61.0m / 259.0m)
NOPAT = 750.7m (EBIT 982.0m * (1 - 23.55%))
Current Ratio = 2.78 (Total Current Assets 3.52b / Total Current Liabilities 1.26b)
Debt / Equity = 0.42 (Debt 1.79b / totalStockholderEquity, last quarter 4.25b)
Debt / EBITDA = 0.77 (Net Debt 926.0m / EBITDA 1.20b)
Debt / FCF = 1.15 (Net Debt 926.0m / FCF TTM 803.0m)
Total Stockholder Equity = 4.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.69% (Net Income 676.0m / Total Assets 7.78b)
RoE = 16.76% (Net Income TTM 676.0m / Total Stockholder Equity 4.03b)
RoCE = 17.01% (EBIT 982.0m / Capital Employed (Equity 4.03b + L.T.Debt 1.74b))
RoIC = 12.85% (NOPAT 750.7m / Invested Capital 5.84b)
WACC = 7.11% (E(7.32b)/V(9.11b) * Re(8.72%) + D(1.79b)/V(9.11b) * Rd(0.67%) * (1-Tc(0.24)))
Discount Rate = 8.72% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.60%
[DCF Debug] Terminal Value 67.45% ; FCFE base≈888.6m ; Y1≈583.4m ; Y5≈266.8m
Fair Price DCF = 73.06 (DCF Value 4.69b / Shares Outstanding 64.2m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -25.40 | EPS CAGR: -52.29% | SUE: -4.0 | # QB: 0
Revenue Correlation: -86.91 | Revenue CAGR: -3.52% | SUE: -1.55 | # QB: 0

Additional Sources for INGR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle